Join the Chronic Obstructive Pulmonary Disease group to help and get support from people like you.
Chronic Obstructive Pulmonary Disease News (Page 4)
Related terms: Chronic Obstructive Pulmonary Disease, Acute, Bronchitis, Chronic, Bronchitis with Airway Obstruction, Chronic Bronchitis, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Disease, COPD, Acute, COPD, Maintenance, Emphysema, Chronic Obstructive Pulmonary Disease, Maintenance, COPD
CHEST: Dupilumab for COPD Tied to Improvement in Health-Related Quality of Life
MONDAY, Oct. 7, 2024 – Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, according to a study presented...
FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease
TUESDAY, Oct. 1, 2024 – The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive...
Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD
Paris and Tarrytown, NY, September 27, 2024. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately controlled...
Blood Test Could Gauge Your Odds for Lung Trouble Like COPD
WEDNESDAY, Sept. 11, 2024 – An experimental blood test could one day help identify people most likely to develop severe lung problems like COPD. The test reviews a panel of 32 proteins in blood that...
Preclinical Blood Test IDs Risk for Respiratory Death, Incident COPD
WEDNESDAY, Sept. 11, 2024 – A proteomic signature indicating increased respiratory susceptibility identifies the risk for respiratory death, incident chronic obstructive pulmonary disease (COPD),...
Voice Changes Warn of COPD Flare-Ups
TUESDAY, Sept. 10, 2024 – A flare-up in COPD can be predicted through changes in a person’s voice, a new study claims. Patients’ voices become higher-pitched, more breathy or hoarse when a flare-up i...
People With Chronic Liver Disease Face More Barriers to Health Care
THURSDAY, Aug. 29, 2024 – People with chronic liver disease (CLD) have a higher likelihood of barriers to health care, according to a study recently published in Gastro Hep Advances. Carrie R. Wong, ...
Americans Are Moving Away From Polluted Areas -- If They Can Afford To
MONDAY, Aug. 26, 2024 – Americans of means are fleeing heavily polluted places in the United States for cleaner locales, a new study has found. Pollution levels are a factor in families’ decision to ...
Improper Inhaler Use by People With COPD Is Common, Worsening Disease
FRIDAY, Aug. 23, 2024 – Millions of people rely on medicines delivered by an inhaler to help manage chronic obstructive pulmonary disorder (COPD). But a new European study finds many patients are...
Two-Thirds of COPD Hospitalized Patients Misuse Inhalers
FRIDAY, Aug. 23, 2024 – Among patients hospitalized with a diagnosis of chronic obstructive pulmonary disorder (COPD), two-thirds of inhalers assessed at admission are misused, according to a study...
FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)
LONDON and RALEIGH, N.C., June 26, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayre...
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the Maintenance Treatment of COPD
24 July 2020 – AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the US for the maintenance treatment of patients with chronic obstructive p...
FDA Approves Duaklir Pressair (aclidinium bromide and formoterol fumarate) for Maintenance Treatment of Chronic Obstructive Pulmonary Disease
Oxford, UK – 1 April 2019: Circassia Pharmaceuticals plc (“Circassia” or “the Company”; LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces the US Food and Dr...
FDA Approves ProAir Digihaler (albuterol sulfate) as the First and Only Digital Inhaler with Built-In Sensors
JERUSALEM--(BUSINESS WIRE)--Dec 21, 2018--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir ® Digihaler™ (a...
FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)
DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today...
Further information
Related drug support groups
prednisone, albuterol, Symbicort, Dupixent, Trelegy Ellipta, montelukast, dupilumab, Anoro Ellipta